Atlas Trials

Glycophosphopeptical AM3 A Potential Adjuvant in the Treatment of SARS-CoV-2

Clinical trial NCT04987554 · UNKNOWN

Trial details

NCT number
NCT04987554
Sponsor
University of Valladolid
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
SARS-CoV-2 Infection
Start date
2021-04-01
Primary completion
2021-12-31
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.